iwasadiver, please include me although I'm passed 80 waiting for the graveyard as flipper suggested:
Those of us who're truly interested in the long term viability and of the DCVax Platform (you obviously included) have watched all these side trials, papers, and presentations regarding the ongoing development of all kinds of peripheral enhancements that more than likely will become important augmentations in the transition from the DCVax-L success (and revenue generator) to the even more powerful Direct line."